Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain

European Journal of Neuroscience

Volumn 12, Issue 10, 2000, Pages 3713-3720

  Keck, Martin E ^a   Sillaber, Inge ^a   Ebner, Karl ^a   Welt, Tobias ^a   Toschi, Nicola ^a   Kaehler, Stefan T ^a,b   Singewald, Nicolas ^a,b   Philippu, Athineos ^a,b   Elbel, Gregor K ^a   Wotjak, Carsten T ^a   Holsboer, Florian ^a   Landgraf, Rainer ^a   Engelmann, Mario ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Computer modelling; Current density; Depression; Microdialysis; Monoamines

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; AMINO ACID DERIVATIVE; ARGININE; ASPARTIC ACID; BIOGENIC AMINE; DOPAMINE; GLUTAMIC ACID; GLUTAMINE; HOMOVANILLIC ACID; NORADRENALIN; SERINE; SEROTONIN; TAURINE; VASOPRESSIN;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; DOPAMINE BRAIN LEVEL; FRONTAL CORTEX; HUMAN; HYPOTHALAMUS; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; VASOPRESSIN RELEASE;

AMINO ACIDS; ANIMALS; ARGININE VASOPRESSIN; BIOGENIC MONOAMINES; ELECTRIC STIMULATION; ELECTRIC STIMULATION THERAPY; HIPPOCAMPUS; HUMANS; HYPOTHALAMUS; MALE; MODELS, NEUROLOGICAL; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, WISTAR; TRANSCRANIAL MAGNETIC STIMULATION; VASOPRESSINS;

EID: 0033787986     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00243.x     Document Type: Article

References (55)

1. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age
2. Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone (CRH) challenge in patients with depression
3. Transcranial magnetic stimulation induces alterations in brain monoamines
4. Current advances and trends in the treatment of depression
5. Dopamine and depression
6. An accurate 3-D model for magnetic stimulation of the brain cortex
7. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression
8. Properties and glial origin of osmotic-dependent release of taurine from the rat supraoptic nucleus
9. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress
10. Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis
11. The effect of taurine on motor behavior, body temperature, and monoamine metabolism in rat brain
12. Transcranial magnetic stimulation
13. Transcranial magnetic stimulation: A neuropsychiatric tool for the 21st century
14. Regional neurotransmitter responses after acute and chronic electroconvulsive shock
15. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A preliminary study
16. Catatonia treated with transcranial magnetic stimulation
17. Transcranial magnetic stimulation in mania: A controlled study
18. The anatomical relationship of the prefrontal cortex with limbic structures and the basal ganglia
19. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: An in vivo microdialysis study
20. Neuroendocrinology of mood disorders
21. Efferent projections of the infralimbic cortex of the rat
22. Repetitive transcranial magnetic stimulation activates specific regions in rat brain
23. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats
24. Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats
25. Dynamism of chemoarchitecture in the hypothalamic paraventricular nucleus
26. Amino acids in rat striatal dialysates: Methodological aspects and changes after electroconvulsive shock
27. Release of vasopressin and oxytocin within the brain and into blood: Microdialysis and antisense targeting
28. Release of vasopressin within the brain contributes to neuroendocrine and behavioral regulation
29. Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: Modulation by treatment with antidepressants and prediction of clinical responsivity
30. Repetitive transcranial magnetic stimulation for posttraumatic stress disorder
31. ECS-induced dopamine release: Effects of electrode placement, anticonvulsant treatment, and stimulus intensity
32. Taurine in rat posterior pituitary: Localization in astrocytes and selective release by hypoosmotic stimulation
33. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: Comparison to hippocampus and basal ganglia
34. Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization
35. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain
36. Simultaneous microdialysis in blood and brain: Oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat
37. Effect of psychotropic drugs on excitatory amino acids in patients undergoing psychosurgery for depression
38. Lasting beneficial effect of rapid rate transcranial magnetic stimulation on slowness in Parkinson's disease
39. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression
40. Repetitive transcranial magnetic stimulation in rats: Evidence for a neuroprotective effect in vitro and in vivo
41. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression
42. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits
43. Magnetic stimulation of the nervous system: Induced electric field in unbounded, semi-infinite, spherical and cylindrical media
44. The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders
45. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: Implications for the pathophysiology of depression
46. Prefrontal cortex efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
47. Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease
48. Release of endogenous GABA in the posterior hypothalamus of the conscious rat; effects of drugs and experimentally induced blood pressure changes
49. The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study
50. Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: An anterograde tracer PHA-L study
51. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: A novel mechanism of regulating adrenocorticotropic hormone secretion?
52. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons
53. Neurochemical effects of electrically and chemically induced seizures: An in vivo microdialysis study in the rat hippocampus